Briefing: High-throughput platform helps engineer fast-acting covalent protein drugs
Strategic angle: A team at Westlake University has developed a new platform to create rapid-acting protein therapeutics.
Editorial Staff
1 min read
Updated 3 months ago
Developed by Bobo Dang and Ting Zhou's team.
Focuses on engineering covalent protein therapeutics.
Utilizes a high-throughput approach for efficiency.